Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

OBJECTIVE: To quantify the regional and global cerebral atrophy rates and assess acceleration rates in healthy controls, subjects with mild cognitive impairment (MCI), and subjects with mild Alzheimer disease (AD). METHODS: Using 0-, 6-, 12-, 18-, 24-, and 36-month MRI scans of controls and subjects with MCI and AD from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, we calculated volume change of whole brain, hippocampus, and ventricles between all pairs of scans using the boundary shift integral. RESULTS: We found no evidence of acceleration in whole-brain atrophy rates in any group. There was evidence that hippocampal atrophy rates in MCI subjects accelerate by 0.22%/year2 on average (p = 0.037). There was evidence of acceleration in rates of ventricular enlargement in subjects with MCI (p = 0.001) and AD (p < 0.001), with rates estimated to increase by 0.27 mL/year2 (95% confidence interval 0.12, 0.43) and 0.88 mL/year2 (95% confidence interval 0.47, 1.29), respectively. A post hoc analysis suggested that the acceleration of hippocampal loss in MCI subjects was mainly driven by the MCI subjects that were observed to progress to clinical AD within 3 years of baseline, with this group showing hippocampal atrophy rate acceleration of 0.50%/year2 (p = 0.003). CONCLUSIONS: The small acceleration rates suggest a long period of transition to the pathologic losses seen in clinical AD. The acceleration in hippocampal atrophy rates in MCI subjects in the ADNI seems to be driven by those MCI subjects who concurrently progressed to a clinical diagnosis of AD

Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers.

Medial temporal lobe atrophy (MTA) and cerebrospinal fluid (CSF) markers of Alzheimer's disease (AD) pathology may aid the early detection of AD in mild cognitive impairment (MCI). However, the relationship between structural and pathological markers is not well understood. Furthermore, while posterior atrophy (PA) is well recognized in AD, its value in predicting conversion from late-onset amnestic MCI to AD is unclear. In this study we used visual ratings of MTA and PA to assess their value in predicting conversion to AD in 394 MCI patients. The relationship of atrophy patterns with CSF Aβ1-42, tau, and p-tau(181) was further investigated in 114 controls, 192 MCI, and 99 AD patients. There was a strong association of MTA ratings with conversion to AD (p < 0.001), with a weaker association for PA ratings (p = 0.047). Specific associations between visual ratings and CSF biomarkers were found; MTA was associated with lower levels of Aβ1-42 in MCI, while PA was associated with elevated levels of tau in MCI and AD, which may reflect widespread neuronal loss including posterior regions. These findings suggest both that posterior atrophy may predict conversion to AD in late-onset MCI, and that there may be differential relationships between CSF biomarkers and regional atrophy patterns

Systematic comparison of different techniques to measure hippocampal subfield volumes in ADNI2

OBJECTIVE: Subfield-specific measurements provide superior information in the early stages of neurodegenerative diseases compared to global hippocampal measurements. The overall goal was to systematically compare the performance of five representative manual and automated T1 and T2 based subfield labeling techniques in a sub-set of the ADNI2 population. METHODS: The high resolution T2 weighted hippocampal images (T2-HighRes) and the corresponding T1 images from 106 ADNI2 subjects (41 controls, 57 MCI, 8 AD) were processed as follows. A. T1-based: 1. Freesurfer + Large-Diffeomorphic-Metric-Mapping in combination with shape analysis. 2. FreeSurfer 5.1 subfields using in-vivo atlas. B. T2-HighRes: 1. Model-based subfield segmentation using ex-vivo atlas (FreeSurfer 6.0). 2. T2-based automated multi-atlas segmentation combined with similarity-weighted voting (ASHS). 3. Manual subfield parcellation. Multiple regression analyses were used to calculate effect sizes (ES) for group, amyloid positivity in controls, and associations with cognitive/memory performance for each approach. RESULTS: Subfield volumetry was better than whole hippocampal volumetry for the detection of the mild atrophy differences between controls and MCI (ES: 0.27 vs 0.11). T2-HighRes approaches outperformed T1 approaches for the detection of early stage atrophy (ES: 0.27 vs.0.10), amyloid positivity (ES: 0.11 vs 0.04), and cognitive associations (ES: 0.22 vs 0.19). CONCLUSIONS: T2-HighRes subfield approaches outperformed whole hippocampus and T1 subfield approaches. None of the different T2-HghRes methods tested had a clear advantage over the other methods. Each has strengths and weaknesses that need to be taken into account when deciding which one to use to get the best results from subfield volumetry

Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease

This is the peer reviewed version of the following article: Xie, L, Wisse, LEM, Pluta, J, et al. Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease. Hum Brain Mapp. 2019; 40: 3431 3451, which has been published in final form at https://doi.org/10.1002/hbm.24607. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.[EN] Medial temporal lobe (MTL) substructures are the earliest regions affected by neurofibrillary tangle pathology-and thus are promising biomarkers for Alzheimer's disease (AD). However, automatic segmentation of the MTL using only T1-weighted (T1w) magnetic resonance imaging (MRI) is challenging due to the large anatomical variability of the MTL cortex and the confound of the dura mater, which is commonly segmented as gray matter by state-of-the-art algorithms because they have similar intensity in T1w MRI. To address these challenges, we developed a novel atlas set, consisting of 15 cognitively normal older adults and 14 patients with mild cognitive impairment with a label explicitly assigned to the dura, that can be used by the multiatlas automated pipeline (Automatic Segmentation of Hippocampal Subfields [ASHS-T1]) for the segmentation of MTL subregions, including anterior/posterior hippocampus, entorhinal cortex (ERC), Brodmann areas (BA) 35 and 36, and parahippocampal cortex on T1w MRI. Cross-validation experiments indicated good segmentation accuracy of ASHS-T1 and that the dura can be reliably separated from the cortex (6.5% mislabeled as gray matter). Conversely, FreeSurfer segmented majority of the dura mater (62.4%) as gray matter and the degree of dura mislabeling decreased with increasing disease severity. To evaluate its clinical utility, we applied the pipeline to T1w images of 663 ADNI subjects and significant volume/thickness loss is observed in BA35, ERC, and posterior hippocampus in early prodromal AD and all subregions at later stages. As such, the publicly available new atlas and ASHS-T1 could have important utility in the early diagnosis and monitoring of AD and enhancing brain-behavior studies of these regions.Northern California Institute for Research and Education; Foundation for the National Institutes of Health; Canadian Institutes of Health Research; Transition Therapeutics; Takeda Pharmaceutical Company; Servier; Piramal Imaging; Pfizer Inc.; Novartis Pharmaceuticals Corporation; Neurotrack Technologies; NeuroRx Research; Meso Scale Diagnostics, LLC.; Lundbeck and Merck & Co., Inc.; Lumosity; Johnson & Johnson Pharmaceutical Research & Development LLC.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; IXICO Ltd.; GE Healthcare; Fujirebio; Genentech, Inc.; F. Hoffmann-La Roche Ltd.; EuroImmun; Eli Lilly and Company; Elan Pharmaceuticals, Inc.; Cogstate and Eisai Inc.; CereSpir, Inc.; Bristol-Myers Squibb Company; Biogen; BioClinica, Inc.; Araclon Biotech; Alzheimer's Drug Discovery Foundation; Alzheimer's Association; AbbVie; National Institute of Biomedical Imaging and Bioengineering; National Institute on Aging; Department of Defense ADNI, Grant/Award Number: W81XWH-12-2-0012; Alzheimer's Disease Neuroimaging Initiative, Grant/Award Number: U01 AG024904; Spain Ministry of Economy, Industry and Competitiveness, Grant/Award Number: DPI2017-87743-R; Foundation Philippe Chatrier; BrightFocus Foundation; National Institutes of Health, Grant/Award Numbers: R01-AG055005, R01-EB017255, P30-AG010124, R01-AG040271, R01-AG056014Xie, L.; Wisse, LEM.; Pluta, J.; De Flores, R.; Piskin, V.; Manjón Herrera, JV.; Wang, H.... (2019). Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease. Human Brain Mapping. 40(12):3431-3451. https://doi.org/10.1002/hbm.24607S343134514012Apostolova, L. G., Green, A. E., Babakchanian, S., Hwang, K. S., Chou, Y.-Y., Toga, A. W., & Thompson, P. M. (2012). Hippocampal Atrophy and Ventricular Enlargement in Normal Aging, Mild Cognitive Impairment (MCI), and Alzheimer Disease. Alzheimer Disease & Associated Disorders, 26(1), 17-27. doi:10.1097/wad.0b013e3182163b62Augustinack, J. C., Huber, K. E., Stevens, A. A., Roy, M., Frosch, M. P., van der Kouwe, A. J. W., … Fischl, B. (2013). Predicting the location of human perirhinal cortex, Brodmann’s area 35, from MRI. NeuroImage, 64, 32-42. doi:10.1016/j.neuroimage.2012.08.071AVANTS, B., EPSTEIN, C., GROSSMAN, M., & GEE, J. (2008). Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Medical Image Analysis, 12(1), 26-41. doi:10.1016/j.media.2007.06.004Bender, A. R., Keresztes, A., Bodammer, N. C., Shing, Y. L., Werkle‐Bergner, M., Daugherty, A. M., … Raz, N. (2017). Optimization and validation of automated hippocampal subfield segmentation across the lifespan. Human Brain Mapping, 39(2), 916-931. doi:10.1002/hbm.23891Berron, D., Vieweg, P., Hochkeppler, A., Pluta, J. B., Ding, S.-L., Maass, A., … Wisse, L. E. M. (2017). A protocol for manual segmentation of medial temporal lobe subregions in 7 Tesla MRI. NeuroImage: Clinical, 15, 466-482. doi:10.1016/j.nicl.2017.05.022BOBINSKI, M., WEGIEL, J., TARNAWSKI, M., BOBINSKI, M., REISBERG, B., DE LEON, M. J., … WISNIEWSKI, H. M. (1997). Relationships between Regional Neuronal Loss and Neurofibrillary Changes in the Hippocampal Formation and Duration and Severity of Alzheimer Disease. Journal of Neuropathology and Experimental Neurology, 56(4), 414-420. doi:10.1097/00005072-199704000-00010Boccardi, M., Bocchetta, M., Apostolova, L. G., Barnes, J., Bartzokis, G., Corbetta, G., … Frisoni, G. B. (2015). Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance. Alzheimer’s & Dementia, 11(2), 126-138. doi:10.1016/j.jalz.2014.02.009Boccardi, M., Bocchetta, M., Morency, F. C., Collins, D. L., Nishikawa, M., Ganzola, R., … Frisoni, G. B. (2015). Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol. Alzheimer’s & Dementia, 11(2), 175-183. doi:10.1016/j.jalz.2014.12.002Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239-259. doi:10.1007/bf00308809Braak, H., & Braak, E. (1995). Staging of alzheimer’s disease-related neurofibrillary changes. Neurobiology of Aging, 16(3), 271-278. doi:10.1016/0197-4580(95)00021-6Chan, D., Fox, N. C., Scahill, R. I., Crum, W. R., Whitwell, J. L., Leschziner, G., … Rossor, M. N. (2001). Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Annals of Neurology, 49(4), 433-442. doi:10.1002/ana.92Chételat, G., Fouquet, M., Kalpouzos, G., Denghien, I., De la Sayette, V., Viader, F., … Desgranges, B. (2008). Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Neuropsychologia, 46(6), 1721-1731. doi:10.1016/j.neuropsychologia.2007.11.037Collins, D. L., & Pruessner, J. C. (2010). Towards accurate, automatic segmentation of the hippocampus and amygdala from MRI by augmenting ANIMAL with a template library and label fusion. NeuroImage, 52(4), 1355-1366. doi:10.1016/j.neuroimage.2010.04.193Coupé, P., Manjón, J. V., Fonov, V., Pruessner, J., Robles, M., & Collins, D. L. (2011). Patch-based segmentation using expert priors: Application to hippocampus and ventricle segmentation. NeuroImage, 54(2), 940-954. doi:10.1016/j.neuroimage.2010.09.018Das, S. R., Mancuso, L., Olson, I. R., Arnold, S. E., & Wolk, D. A. (2015). Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment. Cerebral Cortex, 26(5), 2006-2017. doi:10.1093/cercor/bhv022Das, S. R., Pluta, J., Mancuso, L., Kliot, D., Yushkevich, P. A., & Wolk, D. A. (2015). Anterior and posterior MTL networks in aging and MCI. Neurobiology of Aging, 36, S141-S150.e1. doi:10.1016/j.neurobiolaging.2014.03.041Davies, R. R., Halliday, G. M., Xuereb, J. H., Kril, J. J., & Hodges, J. R. (2009). The neural basis of semantic memory: Evidence from semantic dementia. Neurobiology of Aging, 30(12), 2043-2052. doi:10.1016/j.neurobiolaging.2008.02.005De Flores, R., La Joie, R., & Chételat, G. (2015). Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease. Neuroscience, 309, 29-50. doi:10.1016/j.neuroscience.2015.08.033De Flores, R., La Joie, R., Landeau, B., Perrotin, A., Mézenge, F., de La Sayette, V., … Chételat, G. (2014). Effects of age and Alzheimer’s disease on hippocampal subfields. Human Brain Mapping, 36(2), 463-474. doi:10.1002/hbm.22640De Vita, E., Thomas, D. L., Roberts, S., Parkes, H. G., Turner, R., Kinchesh, P., … Ordidge, R. J. (2003). High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. The British Journal of Radiology, 76(909), 631-637. doi:10.1259/bjr/69317841Delli Pizzi, S., Franciotti, R., Bubbico, G., Thomas, A., Onofrj, M., & Bonanni, L. (2016). Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer’s disease. Neurobiology of Aging, 40, 103-109. doi:10.1016/j.neurobiolaging.2016.01.010Dice, L. R. (1945). Measures of the Amount of Ecologic Association Between Species. Ecology, 26(3), 297-302. doi:10.2307/1932409Dickerson, B. C., Goncharova, I., Sullivan, M. P., Forchetti, C., Wilson, R. S., Bennett, D. A., … deToledo-Morrell, L. (2001). MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease ☆ ☆This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. Neurobiology of Aging, 22(5), 747-754. doi:10.1016/s0197-4580(01)00271-8Ding, S.-L., & Van Hoesen, G. W. (2010). Borders, extent, and topography of human perirhinal cortex as revealed using multiple modern neuroanatomical and pathological markers. Human Brain Mapping, 31(9), 1359-1379. doi:10.1002/hbm.20940Ding, S.-L., Van Hoesen, G. W., Cassell, M. D., & Poremba, A. (2009). Parcellation of human temporal polar cortex: A combined analysis of multiple cytoarchitectonic, chemoarchitectonic, and pathological markers. The Journal of Comparative Neurology, 514(6), 595-623. doi:10.1002/cne.22053Ekstrom, A. D., Bazih, A. J., Suthana, N. A., Al-Hakim, R., Ogura, K., Zeineh, M., … Bookheimer, S. Y. (2009). Advances in high-resolution imaging and computational unfolding of the human hippocampus. NeuroImage, 47(1), 42-49. doi:10.1016/j.neuroimage.2009.03.017Fischl, B. (2012). FreeSurfer. NeuroImage, 62(2), 774-781. doi:10.1016/j.neuroimage.2012.01.021Fischl, B., Stevens, A. A., Rajendran, N., Yeo, B. T. T., Greve, D. N., Van Leemput, K., … Augustinack, J. C. (2009). Predicting the location of entorhinal cortex from MRI. NeuroImage, 47(1), 8-17. doi:10.1016/j.neuroimage.2009.04.033Frisoni, G. B., Jack, C. R., Bocchetta, M., Bauer, C., Frederiksen, K. S., Liu, Y., … Cavedo, E. (2015). The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimer’s & Dementia, 11(2), 111-125. doi:10.1016/j.jalz.2014.05.1756Fukutani, Y., Kobayashi, K., Nakamura, I., Watanabe, K., Isaki, K., & Cairns, N. J. (1995). Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer’s disease. Neuroscience Letters, 200(1), 57-60. doi:10.1016/0304-3940(95)12083-gGlasser, M. F., Sotiropoulos, S. N., Wilson, J. A., Coalson, T. S., Fischl, B., Andersson, J. L., … Jenkinson, M. (2013). The minimal preprocessing pipelines for the Human Connectome Project. NeuroImage, 80, 105-124. doi:10.1016/j.neuroimage.2013.04.127Greene, S. J., & Killiany, R. J. (2011). Hippocampal Subregions are Differentially Affected in the Progression to Alzheimer’s Disease. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, 295(1), 132-140. doi:10.1002/ar.21493Hu, S., Coupé, P., Pruessner, J. C., & Collins, D. L. (2012). Nonlocal regularization for active appearance model: Application to medial temporal lobe segmentation. Human Brain Mapping, 35(2), 377-395. doi:10.1002/hbm.22183Iglesias, J. E., Augustinack, J. C., Nguyen, K., Player, C. M., Player, A., Wright, M., … Van Leemput, K. (2015). A computational atlas of the hippocampal formation using ex vivo , ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. NeuroImage, 115, 117-137. doi:10.1016/j.neuroimage.2015.04.042Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., … Dubois, B. (2016). A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology, 87(5), 539-547. doi:10.1212/wnl.0000000000002923Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., … Harvey, D. (2008). The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging, 27(4), 685-691. doi:10.1002/jmri.21049Kim, H., Caldairou, B., Bernasconi, A., & Bernasconi, N. (2018). Multi-Template Mesiotemporal Lobe Segmentation: Effects of Surface and Volume Feature Modeling. Frontiers in Neuroinformatics, 12. doi:10.3389/fninf.2018.00039Kivisaari, S. L., Probst, A., & Taylor, K. I. (2013). The Perirhinal, Entorhinal, and Parahippocampal Cortices and Hippocampus: An Overview of Functional Anatomy and Protocol for Their Segmentation in MR Images. fMRI, 239-267. doi:10.1007/978-3-642-34342-1_19Krumm, S., Kivisaari, S. L., Probst, A., Monsch, A. U., Reinhardt, J., Ulmer, S., … Taylor, K. I. (2016). Cortical thinning of parahippocampal subregions in very early Alzheimer’s disease. Neurobiology of Aging, 38, 188-196. doi:10.1016/j.neurobiolaging.2015.11.001Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R. C., … Aisen, P. S. (2012). Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology, 72(4), 578-586. doi:10.1002/ana.23650Lehmann, M., Douiri, A., Kim, L. G., Modat, M., Chan, D., Ourselin, S., … Fox, N. C. (2010). Atrophy patterns in Alzheimer’s disease and semantic dementia: A comparison of FreeSurfer and manual volumetric measurements. NeuroImage, 49(3), 2264-2274. doi:10.1016/j.neuroimage.2009.10.056Leow, A. D., Klunder, A. D., Jack, C. R., Toga, A. W., Dale, A. M., Bernstein, M. A., … Thompson, P. M. (2006). Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NeuroImage, 31(2), 627-640. doi:10.1016/j.neuroimage.2005.12.013Leung, K. K., Barnes, J., Ridgway, G. R., Bartlett, J. W., Clarkson, M. J., Macdonald, K., … Ourselin, S. (2010). Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer’s disease. NeuroImage, 51(4), 1345-1359. doi:10.1016/j.neuroimage.2010.03.018Mah, L., Binns, M. A., & Steffens, D. C. (2015). Anxiety Symptoms in Amnestic Mild Cognitive Impairment Are Associated with Medial Temporal Atrophy and Predict Conversion to Alzheimer Disease. The American Journal of Geriatric Psychiatry, 23(5), 466-476. doi:10.1016/j.jagp.2014.10.005Malykhin, N. V., Bouchard, T. P., Camicioli, R., & Coupland, N. J. (2008). Aging hippocampus and amygdala. NeuroReport, 19(5), 543-547. doi:10.1097/wnr.0b013e3282f8b18cMalykhin, N. V., Bouchard, T. P., Ogilvie, C. J., Coupland, N. J., Seres, P., & Camicioli, R. (2007). Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatry Research: Neuroimaging, 155(2), 155-165. doi:10.1016/j.pscychresns.2006.11.011Manjón, J. V., Coupé, P., Buades, A., Fonov, V., Louis Collins, D., & Robles, M. (2010). Non-local MRI upsampling. Medical Image Analysis, 14(6), 784-792. doi:10.1016/j.media.2010.05.010Martin, S. B., Smith, C. D., Collins, H. R., Schmitt, F. A., & Gold, B. T. (2010). Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiology of Aging, 31(7), 1099-1106. doi:10.1016/j.neurobiolaging.2008.08.010Mishra, S., Gordon, B. A., Su, Y., Christensen, J., Friedrichsen, K., Jackson, K., … Benzinger, T. L. S. (2017). AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. NeuroImage, 161, 171-178. doi:10.1016/j.neuroimage.2017.07.050Mufson, E. J., & Pandya, D. N. (1984). Some observations on the course and composition of the cingulum bundle in the rhesus monkey. The Journal of Comparative Neurology, 225(1), 31-43. doi:10.1002/cne.902250105Olsen, R. K., Palombo, D. J., Rabin, J. S., Levine, B., Ryan, J. D., & Rosenbaum, R. S. (2013). Volumetric analysis of medial temporal lobe subregions in developmental amnesia using high‐resolution magnetic resonance imaging. Hippocampus, 23(10), 855-860. doi:10.1002/hipo.22153Olsen, R. K., Yeung, L.-K., Noly-Gandon, A., D’Angelo, M. C., Kacollja, A., Smith, V. M., … Barense, M. D. (2017). Human anterolateral entorhinal cortex volumes are associated with cognitive decline in aging prior to clinical diagnosis. Neurobiology of Aging, 57, 195-205. doi:10.1016/j.neurobiolaging.2017.04.025Palmqvist, S., Schöll, M., Strandberg, O., Mattsson, N., Stomrud, E., Zetterberg, H., … Hansson, O. (2017). Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nature Communications, 8(1). doi:10.1038/s41467-017-01150-xPasquini, L., Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., … Sorg, C. (2016). Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer’s Disease Dementia. Journal of Alzheimer’s Disease, 51(1), 313-326. doi:10.3233/jad-150823Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183-194. doi:10.1111/j.1365-2796.2004.01388.xPetersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., … Jack, C. R. (2009). Mild Cognitive Impairment. Archives of Neurology, 66(12). doi:10.1001/archneurol.2009.266Preston, A. R., Bornstein, A. M., Hutchinson, J. B., Gaare, M. E., Glover, G. H., & Wagner, A. D. (2010). High-resolution fMRI of Content-sensitive Subsequent Memory Responses in Human Medial Temporal Lobe. Journal of Cognitive Neuroscience, 22(1), 156-173. doi:10.1162/jocn.2009.21195Qiu, A., Fennema-Notestine, C., Dale, A. M., & Miller, M. I. (2009). Regional shape abnormalities in mild cognitive impairment and Alzheimer’s disease. NeuroImage, 45(3), 656-661. doi:10.1016/j.neuroimage.2009.01.013Wisse, L. E. M., Gerritsen, L., Zwanenburg, J. J. M., Kuijf, H. J., Luijten, P. R., Biessels, G. J., & Geerlings, M. I. (2012). Subfields of the hippocampal formation at 7T MRI: In vivo volumetric assessment. NeuroImage, 61(4), 1043-1049. doi:10.1016/j.neuroimage.2012.03.023Wisse, L. E. M., Biessels, G. J., & Geerlings, M. I. (2014). A Critical Appraisal of the Hippocampal Subfield Segmentation Package in FreeSurfer. Frontiers in Aging Neuroscience, 6. doi:10.3389/fnagi.2014.00261Witter, M., Van Hoesen, G., & Amaral, D. (1989). Topographical organization of the entorhinal projection to the dentate gyrus of the monkey. The Journal of Neuroscience, 9(1), 216-228. doi:10.1523/jneurosci.09-01-00216.1989Wolk, D. A., & Dickerson, B. C. (2011). Fractionating verbal episodic memory in Alzheimer’s disease. NeuroImage, 54(2), 1530-1539. doi:10.1016/j.neuroimage.2010.09.005Xie, L., Shinohara, R. T., Ittyerah, R., Kuijf, H. J., Pluta, J. B., Blom, K., … Wisse, L. E. M. (2018). Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer’s Disease at 3T and 7T: What Atlas Composition Works Best? Journal of Alzheimer’s Disease, 63(1), 217-225. doi:10.3233/jad-170932Yushkevich, P. A., Piven, J., Hazlett, H. C., Smith, R. G., Ho, S., Gee, J. C., & Gerig, G. (2006). User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage, 31(3), 1116-1128. doi:10.1016/j.neuroimage.2006.01.015Zeineh, M. M., Engel, S. A., Thompson, P. M., & Bookheimer, S. Y. (2001). Unfolding the human hippocampus with high resolution structural and functional MRI. The Anatomical Record, 265(2), 111-120. doi:10.1002/ar.106

A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI.

AbstractAutomated analysis of MRI data of the subregions of the hippocampus requires computational atlases built at a higher resolution than those that are typically used in current neuroimaging studies. Here we describe the construction of a statistical atlas of the hippocampal formation at the subregion level using ultra-high resolution, ex vivo MRI. Fifteen autopsy samples were scanned at 0.13mm isotropic resolution (on average) using customized hardware. The images were manually segmented into 13 different hippocampal substructures using a protocol specifically designed for this study; precise delineations were made possible by the extraordinary resolution of the scans. In addition to the subregions, manual annotations for neighboring structures (e.g., amygdala, cortex) were obtained from a separate dataset of in vivo, T1-weighted MRI scans of the whole brain (1mm resolution). The manual labels from the in vivo and ex vivo data were combined into a single computational atlas of the hippocampal formation with a novel atlas building algorithm based on Bayesian inference. The resulting atlas can be used to automatically segment the hippocampal subregions in structural MRI images, using an algorithm that can analyze multimodal data and adapt to variations in MRI contrast due to differences in acquisition hardware or pulse sequences. The applicability of the atlas, which we are releasing as part of FreeSurfer (version 6.0), is demonstrated with experiments on three different publicly available datasets with different types of MRI contrast. The results show that the atlas and companion segmentation method: 1) can segment T1 and T2 images, as well as their combination, 2) replicate findings on mild cognitive impairment based on high-resolution T2 data, and 3) can discriminate between Alzheimer's disease subjects and elderly controls with 88% accuracy in standard resolution (1mm) T1 data, significantly outperforming the atlas in FreeSurfer version 5.3 (86% accuracy) and classification based on whole hippocampal volume (82% accuracy)

High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas

Available online 4 May 2017The amygdala is composed of multiple nuclei with unique functions and connections in the limbic system and to the rest of the brain. However, standard in vivo neuroimaging tools to automatically delineate the amygdala into its multiple nuclei are still rare. By scanning postmortem specimens at high resolution (100–150 µm) at 7 T field strength (n = 10), we were able to visualize and label nine amygdala nuclei (anterior amygdaloid, cortico-amygdaloid transition area; basal, lateral, accessory basal, central, cortical medial, paralaminar nuclei). We created an atlas from these labels using a recently developed atlas building algorithm based on Bayesian inference. This atlas, which will be released as part of FreeSurfer, can be used to automatically segment nine amygdala nuclei from a standard resolution structural MR image. We applied this atlas to two publicly available datasets (ADNI and ABIDE) with standard resolution T1 data, used individual volumetric data of the amygdala nuclei as the measure and found that our atlas i) discriminates between Alzheimer's disease participants and age-matched control participants with 84% accuracy (AUC=0.915), and ii) discriminates between individuals with autism and age-, sex- and IQ-matched neurotypically developed control participants with 59.5% accuracy (AUC=0.59). For both datasets, the new ex vivo atlas significantly outperformed (all p < .05) estimations of the whole amygdala derived from the segmentation in FreeSurfer 5.1 (ADNI: 75%, ABIDE: 54% accuracy), as well as classification based on whole amygdala volume (using the sum of all amygdala nuclei volumes; ADNI: 81%, ABIDE: 55% accuracy). This new atlas and the segmentation tools that utilize it will provide neuroimaging researchers with the ability to explore the function and connectivity of the human amygdala nuclei with unprecedented detail in healthy adults as well as those with neurodevelopmental and neurodegenerative disorders.This work was supported by the PHS grant DA023427 and NICHD/ NIH grant F32HD079169 (Z.M.S); Feodor Lynen Postdoctoral Fellowship of the Alexander von Humboldt Foundation (D.K.); R21(MH106796), R21 (AG046657) and K01AG28521 (J.C.A.), the National Cancer Institute (1K25CA181632-01) as well as the Genentech Foundation (M.R.); the European Union's Horizon 2020 Marie Sklodowska-Curie grant agreement No 654911 (project ”THALAMODEL”) and ERC Starting Grant agreement No 677697 (project “BUNGEE-TOOLS”); and the Spanish Ministry of Economy and Competitiveness (MINECO) reference TEC2014-51882-P (J.E.I.); and the NVIDIA hardware award (M.R. and J.E.I.). Further support for this research was provided in part by the National Institute for Biomedical Imaging and Bioengineering (P41EB015896, R01EB006758, R21EB018907, R01EB019956, R01- EB013565), the National Institute on Aging (5R01AG008122, R01AG016495), the National Institute of Diabetes and Digestive and Kidney Diseases (1-R21-DK-108277-01), the National Institute for Neurological Disorders and Stroke (R01NS0525851, R21NS072652, R01NS070963, R01NS083534, 5U01NS086625), the Massachusetts ADRC (P50AG005134) and was made possible by the resources provided by Shared Instrumentation Grants 1S10RR023401, 1S10RR019307, and 1S10RR023043. Additional support was provided by the NIH Blueprint for Neuroscience Research (5U01-MH093765), part of the multi-institutional Human Connectome Project. In addition, BF has a financial interest in CorticoMetrics, a company whose medical pursuits focus on brain imaging and measurement technologies. BF's interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. The collection and sharing of the ADNI MRI data used in the evaluation was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2- 0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www. fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California

Heritability and reliability of automatically segmented human hippocampal formation subregions

The human hippocampal formation can be divided into a set of cytoarchitecturally and functionally distinct subregions, involved in different aspects of memory formation. Neuroanatomical disruptions within these subregions are associated with several debilitating brain disorders including Alzheimer's disease, major depression, schizophrenia, and bipolar disorder. Multi-center brain imaging consortia, such as the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) consortium, are interested in studying disease effects on these subregions, and in the genetic factors that affect them. For large-scale studies, automated extraction and subsequent genomic association studies of these hippocampal subregion measures may provide additional insight. Here, we evaluated the test-retest reliability and transplatform reliability (1.5 T versus 3 T) of the subregion segmentation module in the FreeSurfer software package using three independent cohorts of healthy adults, one young (Queensland Twins Imaging Study, N=39), another elderly (Alzheimer's Disease Neuroimaging Initiative, ADNI-2, N=163) and another mixed cohort of healthy and depressed participants (Max Planck Institute, MPIP, N=598). We also investigated agreement between the most recent version of this algorithm (v6.0) and an older version (v5.3), again using the ADNI-2 and MPIP cohorts in addition to a sample from the Netherlands Study for Depression and Anxiety (NESDA) (N=221). Finally, we estimated the heritability (h(2)) of the segmented subregion volumes using the full sample of young, healthy QTIM twins (N=728). Test-retest reliability was high for all twelve subregions in the 3 T ADNI-2 sample (intraclass correlation coefficient (ICC)=0.70-0.97) and moderate-to-high in the 4 TQTIM sample (ICC=0.5-0.89). Transplatform reliability was strong for eleven of the twelve subregions (ICC=0.66-0.96); however, the hippocampal fissure was not consistently reconstructed across 1.5 T and 3 T field strengths (ICC=0.47-0.57). Between-version agreement was moderate for the hippocampal tail, subiculum and presubiculum (ICC=0.78-0.84; Dice Similarity Coefficient (DSC)=0.55-0.70), and poor for all other subregions (ICC=0.34-0.81; DSC=0.28-0.51). All hippocampal subregion volumes were highly heritable (h(2)=0.67-0.91). Our findings indicate that eleven of the twelve human hippocampal subregions segmented using FreeSurfer version 6.0 may serve as reliable and informative quantitative phenotypes for future multi-site imaging genetics initiatives such as those of the ENIGMA consortium. (C) 2016 The Authors. Published by Elsevier Inc

Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE

AbstractQuantitative measurements of change in β-amyloid load from Positron Emission Tomography (PET) images play a critical role in clinical trials and longitudinal observational studies of Alzheimer's disease. These measurements are strongly affected by methodological differences between implementations, including choice of reference region and use of partial volume correction, but there is a lack of consensus for an optimal method. Previous works have examined some relevant variables under varying criteria, but interactions between them prevent choosing a method via combined meta-analysis. In this work, we present a thorough comparison of methods to measure change in β-amyloid over time using Pittsburgh Compound B (PiB) PET imaging.MethodsWe compare 1,024 different automated software pipeline implementations with varying methodological choices according to four quality metrics calculated over three-timepoint longitudinal trajectories of 129 subjects: reliability (straightness/variance); plausibility (lack of negative slopes); ability to predict accumulator/non-accumulator status from baseline value; and correlation between change in β-amyloid and change in Mini Mental State Exam (MMSE) scores.Results and conclusionFrom this analysis, we show that an optimal longitudinal measure of β-amyloid from PiB should use a reference region that includes a combination of voxels in the supratentorial white matter and those in the whole cerebellum, measured using two-class partial volume correction in the voxel space of each subject's corresponding anatomical MR image

REGISTRATION AND SEGMENTATION OF BRAIN MR IMAGES FROM ELDERLY INDIVIDUALS

Quantitative analysis of the MRI structural and functional images is a fundamental component in the assessment of brain anatomical abnormalities, in mapping functional activation onto human anatomy, in longitudinal evaluation of disease progression, and in computer-assisted neurosurgery or surgical planning. Image registration and segmentation is central in analyzing structural and functional MR brain images. However, due to increased variability in brain morphology and age-related atrophy, traditional methods for image registration and segmentation are not suitable for analyzing MR brain images from elderly individuals. The overall goal of this dissertation is to develop algorithms to improve the registration and segmentation accuracy in the geriatric population. The specific aims of this work includes 1) to implement a fully deformable registration pipeline to allow a higher degree of spatial deformation and produce more accurate deformation field, 2) to propose and validate an optimum template selection method for atlas-based segmentation, 3) to propose and validate a multi-template strategy for image normalization, which characterizes brain structural variations in the elderly, 4) to develop an automated segmentation and localization method to access white matter integrity (WMH) in the elderly population, and finally 5) to study the default-mode network (DMN) connectivity and white matter hyperintensity in late-life depression (LLD) with the developed registration and segmentation methods. Through a series of experiments, we have shown that the deformable registration pipeline and the template selection strategies lead to improved accuracy in the brain MR image registration and segmentation, and the automated WMH segmentation and localization method provides more specific and more accurate information about volume and spatial distribution of WMH than traditional visual grading methods. Using the developed methods, our clinical study provides evidence for altered DMN connectivity in LLD. The correlation between WMH volume and DMN connectivity emphasizes the role of vascular changes in LLD's etiopathogenesis